← Back to headlines
EU Approves $4.8 Billion Merger of BioMarin and Amicus
The European Union has granted approval for the $4.8 billion merger between US pharmaceutical companies BioMarin and Amicus, clearing a major regulatory hurdle for the deal.
7 Apr, 20:39 — 7 Apr, 20:39
Sources
Showing 1 of 1 sources
